Literature DB >> 16892793

The black box warning for topical calcineurin inhibitors: looking outside the box.

Luz Fonacier1, Ernest N Charlesworth, Jonathan M Spergel, Donald Y M Leung.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16892793     DOI： 10.1016/S1081-1206(10)61381-6

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  3 in total

1.  EBV-positive PEL-like lymphoma that developed in the course of antisynthetase syndrome treated with tacrolimus.

Authors:  Kimi Okada; Shoji Asakura; Tomofumi Yano; Takumi Kishimoto
Journal:  Int J Hematol       Date:  2018-03-07       Impact factor: 2.490

Review 2.  The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy.

Authors:  Johannes Ring; Matthias Möhrenschlager; Verena Henkel
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

3.  Atopic dermatitis and the atopic march: what is new?

Authors:  Annalisa Patrizi; Alessandro Pileri; Federica Bellini; Beatrice Raone; Iria Neri; Giampaolo Ricci
Journal:  J Allergy (Cairo)       Date:  2011-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.